Captrust Financial Advisors Increases Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Captrust Financial Advisors increased its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 39.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,548 shares of the medical instruments supplier’s stock after purchasing an additional 6,609 shares during the period. Captrust Financial Advisors’ holdings in DENTSPLY SIRONA were worth $447,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Pacer Advisors Inc. raised its holdings in DENTSPLY SIRONA by 15,105.1% during the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock valued at $85,478,000 after acquiring an additional 4,473,972 shares during the period. Nuance Investments LLC grew its position in shares of DENTSPLY SIRONA by 25.0% during the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier’s stock worth $257,103,000 after purchasing an additional 2,708,097 shares in the last quarter. Norges Bank bought a new stake in DENTSPLY SIRONA during the 4th quarter valued at approximately $45,730,000. AQR Capital Management LLC lifted its holdings in DENTSPLY SIRONA by 245.1% in the 4th quarter. AQR Capital Management LLC now owns 2,893,023 shares of the medical instruments supplier’s stock worth $54,389,000 after purchasing an additional 2,054,767 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its stake in DENTSPLY SIRONA by 18.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier’s stock worth $238,186,000 after purchasing an additional 1,975,404 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on XRAY shares. Barrington Research boosted their target price on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the stock an “outperform” rating in a report on Monday, May 12th. UBS Group decreased their price target on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a “buy” rating on the stock in a research note on Friday, May 9th. Mizuho cut their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating for the company in a research report on Thursday, March 13th. StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday, May 9th. Finally, Robert W. Baird cut their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a report on Friday, February 28th. Eleven equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $20.36.

Insider Activity at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 15,142 shares of the firm’s stock in a transaction dated Monday, March 3rd. The stock was acquired at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the transaction, the director now owns 81,971 shares in the company, valued at $1,353,341.21. This trade represents a 22.66% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.50% of the stock is owned by company insiders.

DENTSPLY SIRONA Stock Down 0.4%

Shares of XRAY opened at $16.63 on Tuesday. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 52-week low of $12.16 and a 52-week high of $28.44. The company has a market cap of $3.31 billion, a PE ratio of -8.03, a P/E/G ratio of 1.80 and a beta of 0.92. The business has a fifty day moving average of $14.43 and a 200 day moving average of $17.25.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, beating the consensus estimate of $0.29 by $0.14. The company had revenue of $879.00 million for the quarter, compared to the consensus estimate of $854.75 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm’s revenue was down 7.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.42 EPS. On average, sell-side analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 3.85%. The ex-dividend date was Friday, March 28th. DENTSPLY SIRONA’s payout ratio is currently -14.10%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.